Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 10, 2026, 12:59 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 25–48 of 976 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Endothelial Clear all

Conditions: Chronic Kidney Disease
Interventions: Resistance exercise training; Behavioral
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 21 Years and older
Enrollment: 34 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: HIV, Acquired Immunodeficiency Syndrome, Cardiovascular Diseases
Interventions: Exercise Program, Control Group; Behavioral
Lead sponsor: University of Miami; Other
Eligibility: 2 Weeks to 25 Years
Enrollment: 16 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2015
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Cystic Fibrosis
Interventions: Sildenafil (Acute-1 hour), Sildenafil (Subchronic-4 weeks), Placebo; Drug
Lead sponsor: Augusta University; Other
Eligibility: 18 Years and older
Enrollment: 19 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2018
U.S. locations: 1
States / cities: Augusta, Georgia

Conditions: Obesity, Overweight
Interventions: Active Concord Grape Juice 12 oz per day, Placebo Grape Juice 12 oz per day; Other
Lead sponsor: Boston University; Other
Eligibility: 50 Years and older
Enrollment: 77 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Cystic Fibrosis
Interventions: BH4 5mg, BH4 20mg, Antioxidant Cocktail; Drug · Dietary Supplement
Lead sponsor: Augusta University; Other
Eligibility: 7 Years and older
Enrollment: 64 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2016
U.S. locations: 1
States / cities: Augusta, Georgia

Conditions: Healthy
Interventions: High potassium dietary education/counseling, Low sodium dietary education/counseling; Behavioral
Lead sponsor: Florida State University; Other
Eligibility: 18 Years to 45 Years
Enrollment: 32 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Tallahassee, Florida

Conditions: Cardiomyopathy, Heart Failure
Interventions: POMx, pomegranate polyphenol extract, Sugar Pill; Drug
Lead sponsor: Jennifer Cowger , MD, MS; Other
Eligibility: 21 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 2
States / cities: Ann Arbor, Michigan

Conditions: Heart Failure, Depression
Interventions: sertraline; Drug
Lead sponsor: Yale University; Other
Eligibility: 21 Years and older
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2009
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Coronary Artery Disease
Interventions: Grape seed extract and ascorbic acid; Dietary Supplement
Lead sponsor: Boston University; Other
Eligibility: 21 Years to 80 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Leukemia, Myelodysplastic Syndromes
Interventions: bevacizumab, cytarabine, mitoxantrone hydrochloride; Biological · Drug
Lead sponsor: University of Maryland, Baltimore; Other
Eligibility: 18 Years to 120 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2004
U.S. locations: 3
States / cities: Atlanta, Georgia • Baltimore, Maryland

Conditions: Phenylketonuria
Interventions: Kuvan, Meal Challenge; Drug · Other
Lead sponsor: Emory University; Other
Eligibility: 10 Years to 45 Years
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: Decatur, Georgia

Conditions: Endothelial Function
Interventions: Blood flow restriction resistance training; Behavioral
Lead sponsor: Hirofumi Tanaka; Other
Eligibility: 18 Years to 40 Years
Enrollment: 26 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Diabetes, Cardiovascular Diseases, Prediabetes
Interventions: Apple, Placebo; Dietary Supplement
Lead sponsor: Florida State University; Other
Eligibility: 45 Years to 65 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Tallahassee, Florida

Conditions: Hypertension
Interventions: Concord Grape Juice; Dietary Supplement
Lead sponsor: Boston University; Other
Eligibility: 21 Years to 75 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2009
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Endothelial Dysfunction, Autonomic Dysfunction
Interventions: Resistance Exercise with Blood Flow Restriction, High-intensity Resistance Exercise; Other
Lead sponsor: Kent State University; Other
Eligibility: 18 Years to 30 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Kent, Ohio

Conditions: Diabetic Macular Edema, Cataract
Interventions: Aflibercept injected Pre- and Post-operatively, Aflibercept injected intraoperatively; Drug
Lead sponsor: Emory University; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020
U.S. locations: 2
States / cities: Atlanta, Georgia

Conditions: Hematopoietic Stem Cell Transplant (HSCT), Endothelial Injury
Interventions: Pravastatin; Drug
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: 2 Years to 25 Years
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Renal Cell Carcinoma
Interventions: Cabozantinib tablets, Everolimus (Afinitor) tablets; Drug
Lead sponsor: Exelixis; Industry
Eligibility: 18 Years and older
Enrollment: 658 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2021
U.S. locations: 59
States / cities: Birmingham, Alabama • Anchorage, Alaska • Gilbert, Arizona + 46 more

Conditions: Hypertension, Cardiovascular Diseases, Vascular Diseases
Interventions: 25 g of Freeze-dried Strawberry Powder, 50 g of Freeze-dried Strawberry Powder, Placebo Powder; Dietary Supplement
Lead sponsor: Florida State University; Other
Eligibility: 45 Years to 65 Years · Female only
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Tallahassee, Florida

Conditions: Acute Myocardial Infarction
Interventions: Not listed
Lead sponsor: Scripps Translational Science Institute; Other
Eligibility: 18 Years to 80 Years
Enrollment: 664 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2025
U.S. locations: 1
States / cities: La Jolla, California

Conditions: Gastric Cancer, Adenocarcinoma
Interventions: ramucirumab, Placebo, Best Supportive Care (BSC); Biological · Drug · Other
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 18 Years and older
Enrollment: 355 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2015
U.S. locations: 14
States / cities: Bakersfield, California • La Jolla, California • Redlands, California + 11 more

Conditions: Choroidal Neovascularization, Age-Related Maculopathy
Interventions: dexamethasone, ranibizumab, sham; Drug · Biological · Other
Lead sponsor: Allergan; Industry
Eligibility: 50 Years and older
Enrollment: 243 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 1
States / cities: Boynton Beach, Florida

Conditions: Coronary Artery Bypass Graft, CABG
Interventions: IMT, Sham-IMT; Device
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years and older
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 2
States / cities: Chicago, Illinois

Conditions: Cardiovascular Disease, Diabetes Mellitus, Type 2
Interventions: Goodbelly first, Placebo first; Dietary Supplement
Lead sponsor: Medical College of Wisconsin; Other
Eligibility: 40 Years to 80 Years
Enrollment: 215 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2025
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Search by objective public record fields.

Resistance Exercise Training in Chronic Kidney Disease

Evaluating an Exercise Program to Reduce Cardiovascular Risk Factors in Children Infected With HIV

Blood Flow and Vascular Function in Cystic Fibrosis

Effect of Concord Grape Juice on Endothelial Function

Cystic Fibrosis and Endothelial Function: At Rest and During Exercise

Sodium vs Potassium Education to Improve Vascular Health

The Impact of Pomegranate Extract on Chronic Cardiomyopathy Complicated by Renal Insufficiency (ImPrOVE): a Pilot Study

Vascular Effects of Sertraline in Heart Failure

Effect of Grape Seed Extract Plus Ascorbic Acid on Endothelial Function

Bevacizumab, Cytarabine, and Mitoxantrone on Treating Patients With Hematologic Cancers

Phenylketonuria, Oxidative Stress, and BH4

Blood Flow Restriction Resistance Training Intervention on Vascular Function

The Effects of Apple Consumption on Cardiovascular Health in Prediabetics and Type 2 Diabetics

Blood Pressure Lowering Effects of Grape Juice

Upper- and Lower-body Resistance Exercise With and Without Blood Flow Restriction on Hemodynamics and Vascular Function

Cataract DME - Peri vs. Intraop

Pravastatin as a Prophylactic to Reduce Endothelial Injury in Pediatric Patients With Elevated Body Mass Index

A Study of Cabozantinib (XL184) vs Everolimus in Subjects With Metastatic Renal Cell Carcinoma

The Effects of Strawberries on Blood Pressure in Postmenopausal Women

Molecular and Morphologic Characterization of Circulating Endothelial Cells

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Participants With Gastric Cancer and Adenocarcinoma

Safety and Efficacy of a New Treatment as Adjunctive Therapy to Anti-vascular Endothelial Growth Factor (Anti-VEGF) Treatment in Patients With Age-Related Macular Degeneration (AMD)

High-intensity Inspiratory Muscle Training as a Pre-cardiac Rehabilitation in Heart Disease

Effect of Probiotic Supplementation on Endothelial Function II